HEALTHCARE

Market Highlights: The growth of the global somatostatin analogs market is driven by various factors such as increasing research & development activity in the somatostatin analogs market and increasing numbers of players involved in the development of generic versions of somatostatin analogs. Some of the key companies operating in this market are Nodysis Pharma, United Biotech, Wockhardt, Neiss, Sun Pharma, and Ferring Holding SA, among others. In addition, the rising incidence rate of the NETs; and increasing efforts by government bodies and public and private organizations to increase awareness about Acromegaly are some of the other factors for the growth of the somatostatin analogs market. According to MRFR analysis, the global Somatostatin Analogs Market is expected to register a CAGR of 6.8% during the forecast period of 2019 to 2025 and is anticipated to reach USD 8,640 million by 2025. However, lack of awareness leading to a high number of undiagnosed people, a

Market Highlights Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, which is also known as hip prosthesis. Hip replacement surgery can be performed as a hemi (half) replacement or total replacement. The growth of the global hip implants market is driven by various factors, such as the introduction of custom-made implants and the growing geriatric population. Increased product launches, mergers, acquisitions, and partnerships of the major players of the market attributed to the growth of the market. However, stringent government regulations on all-metal hip implants and an increase in the number of product recalls are projected to hamper the growth of the global hip implants market. According to MRFR analysis, the global Hip Implants Market is expected to register a CAGR of 4.1% during the forecast period of 2019 to 2025 and is expected to reach USD 9,300 million by 2025. Several market players currently dominate the global

Market Highlights: Antibiotics are powerful medicines that fight bacterial infections. They either stop bacteria from reproducing or destroy them. Several types of antibiotics are available, and they are generally available with a prescription in most countries. According to MRFR analysis, the global Antibiotics Market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 and was valued at USD 51,835 million in 2018. The growth of global antibiotics market is driven by various factors such as increasing efforts undertaken by major companies for the development of advanced antibiotic products, development of generic drugs, increasing approval of antibiotic drugs, rise in incidence of chronic and infectious diseases, growing investment opportunities by biotech companies in research and development, is expected to drive the growth of the global antibiotics market. Key Players: ·          Novartis AG ·          Bristol-Myers Squibb Company

Market Highlights: Vitiligo Is A Skin Disorder That Causes White Patches To Appear On The Skin. These Patches Occur Because The Melanocytes Are Destroyed, Leaving Areas Of Skin With No Pigment At All. It Can Affect Any Skin Part Of The Body. According To Mrfr Analysis, The Global Vitiligo Treatment Market Is Expected To Register A Cagr Of ~5.6% During The Forecast Period Of 2019 To 2025 And Was Valued At Usd 1.22 Billion In 2018. The Growth Of The Global Vitiligo Treatment Market Is Driven By Various Factors Such As Emerging Therapies For Skin Disorders, Increasing Healthcare Expenditure, Lifestyle Changes. However, The Lack Of Skilled Professionals Is Expected To Curb The Growth Of The Global Vitiligo Treatment Market. Several Market Players Currently Dominate The Global Vitiligo Treatment Market. The Key Players Are Involved In Product Launches And Strategic Collaborations To Strengthen Their Market Positions. For Instance, Incyte Corporation Reported Positive Results From

Market Highlights: Stem cells (SC) are a class of undifferentiated biological cells of a multicellular organism that have the ability to produce indefinite cells of the same type, from which certain types of cells (proliferation and replication) can be produced by differentiation in the body through early life and growth. According to MRFR analysis, the global Stem Cell Banking Market is expected to register a CAGR of 9.8% during the forecast period of 2019 to 2025 and is expected to reach USD 12,056.7 million by 2025. The stem has the potential to develop into several different cell types, from muscle cells to brain cells. Factors representing the growth of the market are rising use of therapeutic potential of stem cells, increasing investments in stem cell-based research, surging number of hematopoietic stem cell transplantation (HSCT) procedures, and growing newborn population. For instance, in August 2018, the Ministry of Science and Technology (MOST) of the Governme

Market Highlights: Biopharmaceuticals are also known as biological, medical products, or biologics, are pharmaceutical drugs manufactured, extracted, or synthesized using biological sources, such as bacteria, yeast, and mammalian cells. According to MRFR analysis, the global Biopharmaceuticals Market is expected to register a CAGR of 8.99% during the forecast period of 2019 to 2025 and was valued at USD 238,192.7 million in 2018. The global biopharmaceuticals market is growing owing to various factors such as increasing investment by major companies on research & development of biopharmaceuticals and increasing acceptance for biopharmaceuticals due to their ability to treat the previously untreatable diseases. Furthermore, the number of geriatric population is, tremendously, the incidence rate of chronic diseases is also high, and technological advancements are growing which are also expected to fuel the market growth. However, the entry of low-cost biosimilars, risk

Market Highlights: Pseudomonas Aeruginosa is a soil bacterium that causes diseases in a plant, animal and humans. It has an antibiotic resistance property because of which it creates life-threatening conditions that are difficult to treat. Pseudomonas Aeruginosa is one of the key reasons for having surgical site infection and hospital-acquired infection in patient hospitalized for a longer period. It is estimated that around 1.7 million patient suffers from hospital acquire infection and 99,000 dies each year from the same. According to MRFR analysis, the global Pseudomonas Aeruginosa Treatment Market is expected to register a CAGR of ~7% during the forecast period of 2019 to 2025 and is likely to be valued at USD 7.5 billion in 2025. The growth of the global Pseudomonas Aeruginosa treatment market is determined by numerous factors such as an increasing number of surgeries, a growing geriatric population, increasing cases of hospital-acquired infection, which is directly respo